Loading...
Uploaded by moneycontrol on May 30, 2011
Sun Pharmaceutical is eyeing revenue growth of 28-30% in FY12, said Uday Baldota of Sun Pharma. In an interview to CNBC-TV18, Baldota said that Taro Pharmaceutical Industries reported strong margins this quarter.
News & Politics
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (0)